|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-7-23
|
|
pubmed:abstractText |
To describe and report the effect of intravitreal bevacizumab (Avastin) as primary treatment for secondary choroidal neovascularization (CNV) after choroidal rupture due to blunt-head trauma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1573-2630
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
289-91
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:18825317-Adult,
pubmed-meshheading:18825317-Angiogenesis Inhibitors,
pubmed-meshheading:18825317-Antibodies, Monoclonal,
pubmed-meshheading:18825317-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:18825317-Choroid,
pubmed-meshheading:18825317-Choroidal Neovascularization,
pubmed-meshheading:18825317-Craniocerebral Trauma,
pubmed-meshheading:18825317-Fluorescein Angiography,
pubmed-meshheading:18825317-Humans,
pubmed-meshheading:18825317-Injections,
pubmed-meshheading:18825317-Male,
pubmed-meshheading:18825317-Recovery of Function,
pubmed-meshheading:18825317-Retina,
pubmed-meshheading:18825317-Rupture,
pubmed-meshheading:18825317-Tomography, Optical Coherence,
pubmed-meshheading:18825317-Visual Acuity,
pubmed-meshheading:18825317-Vitreous Body,
pubmed-meshheading:18825317-Wounds, Nonpenetrating
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Intravitreal bevacizumab injection in patients with choroidal neovascularization due to choroid rupture after blunt-head trauma.
|
|
pubmed:affiliation |
Department of Ophthalmology, Istanbul Science University, Istanbul, Turkey. artunayo@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
